AOD-9604
AOD-9604 is a modified fragment of human growth hormone, amino acids 177 to 191. The pharmacy dispenses it as a 500mcg troche and a 500mcg rapid-dissolve tablet, compounded to order. Compounded medications are not FDA-approved, and a licensed provider reviews your history before prescribing.
Pharmacy shipping: $20 added once per medication order.
About this treatment
Explore the research behind a growth hormone fragment.
AOD-9604 was developed to investigate the part of growth hormone associated with fat metabolism. IAM lists a troche and rapid-dissolve tablet, giving your provider a specific preparation to discuss alongside your weight and metabolic health goals.
A fragment with a specific research purpose
AOD-9604 is a synthetic modification of a short segment of human growth hormone. Researchers designed it to explore lipid metabolism, including the breakdown and storage of fat. It is a different molecule from full-length growth hormone, so its name should not be read as hormone replacement or as a treatment for growth hormone deficiency.
Connect the research with your actual goal
Body weight, waist size, blood sugar and physical function describe different aspects of metabolic health. Be specific about which concern brings you to the visit. Understanding AOD-9604's research focus on fat metabolism gives the conversation a starting point, while your health history and existing treatment help define what you want to assess.
Know what the mouth-dissolving form means
IAM lists a troche and a rapid-dissolve tablet that are held in the mouth. Ask which preparation is being considered, what is in it and what the pharmacy's label means for use and storage. Your provider can discuss how its research fits with the other options relevant to your goals and how progress would be assessed.
Research and product information
AOD-9604 has no established weight-loss benefit. FDA's review found that most available human studies did not show a benefit over placebo. Those studies do not establish effectiveness of IAM's mouth-dissolving preparations, which are compounded and are not FDA-approved.
- Ng et al. AOD9604 and metabolic pathways in an animal model (2000)
- FDA: AOD-9604 pharmacy compounding scientific review (December 2024)
- FDA: understanding compounded drug preparations
Sources checked .
Your path to AOD-9604
Complete the assessment
Share your body composition goals, nutrition, and health history.
Provider review
A licensed provider decides whether AOD-9604 fits your plan and what to prescribe.
Care coordination
Your care team coordinates the prescription after provider approval.
About this treatment
What it is
AOD-9604 is the 177 to 191 fragment of human growth hormone, not full growth hormone. IAM dispenses it as a compounded troche or rapid-dissolve tablet, and your provider decides which is prescribed.
Who it's for
Adults whose provider decides a non-injectable compounded peptide fits their plan, after reviewing their history. Ask your provider whether it belongs in yours.
Forms we dispense
Troche 500mcg · RDT 500mcg
A licensed provider reviews your history and requests labs when clinically appropriate before prescribing.
Prescriptions are coordinated with our licensed US pharmacy partner, with dosing supplies included when needed.
We do not sell pharmaceuticals online. Every prescription comes after a full provider review.
